title: Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?
authors.forename: S C
authors.initials: SC
authors.lastname: Toyama
authors.forename: R P
authors.initials: RP
authors.lastname: Iacono
mesh_terms: D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D017374:Paroxetine / Q000627:therapeutic use; D012642:Selegiline / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline
chemical_list: D015057:1-Naphthylamine; D005473:Fluoxetine; D017374:Paroxetine; D012642:Selegiline; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline